Photo of Professor Stephen Porter

Professor Stephen Porter

Telephone:

Email:

Location:

  • Royal National ENT and Eastman Dental Hospitals

GMC/GDC number:

56791

Professional background

Stephen Porter is director and professor of oral medicine of UCL Eastman Dental Institute. 

His clinical interests are the non-surgical management of complex immunologically-mediated and potentially malignant disease of the mouth and salivary glands.

His research interests centre upon the oral aspects of viral infection and the aetiology and detection of potentially malignant oral disease.

Specialties

Research interests

  • Non-surgical management of disorders of the oral mucosa
  • Salivary glands
  • Abnormalities of oral sensation

Publications

Beder Ribeiro, C. M., Ferrer, I., Santos de Farias, A. B., Fonseca, D. D., Morais Silva, I. H., Monteiro Gueiros, L. A., Porter SR, Leao, J. C. (2014).Oral and genital HPV genotypic concordance between sexual partners. Clin Oral Investig, 18 (1), 261-268. doi:10.1007/s00784-013-0959-6

Needleman, I., Ashley, P., Petrie, A., Fortune, F., Turner, W., Jones, J, Porter, S. (2014).Oral health and impact on performance of athletes participating in the london 2012 olympic games. Br J Sports Med, 48 (7), 644-645. doi:10.1136/bjsports-2014-093494.224

Bedogni, A., Fedele, S., Bedogni, G., Scoletta, M., Arduino, P., Favia, G., Porter S R, Fung Polly, P. L. (2014).Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease. British Journal of Oral and Maxillofacial Surgery. doi:10.1016/j.bjoms.2014.04.009

Fedele, S., Fung, P. P., Bamashmous, N., Petrie, A., & Porter, S. (2014).Long-term effectiveness of intralesional triamcinolone acetonide therapy in orofacial granulomatosis: an observational cohort study. Br J Dermatol, 170 (4), 794-801. doi:10.1111/bjd.12655

Al-Hamad, A., Porter, S., & Fedele, S. (2015).Orofacial Granulomatosis. Dermatologic Clinics, 33 (3), 433-446. doi:10.1016/j.det.2015.03.008

Al-Hamad, A., Mercadante, V., Besi, E., Porter, S., & Fedele, S. (2015).Salivary Electrostimulation in Primary Sjogren's Syndrome: Results from LEONIDAS-1 Feasibility Study. Scandinavian Journal of Immunology, 81 (5), 357-358.

Fedele, S., Bedogni, G., Scoletta, M., Favia, G., Colella, G., Agrillo, A., Porter S R, Bedogni, A. (2015).Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed. Br J Oral Maxillofac Surg, 53 (1), 13-17. doi:10.1016/j.bjoms.2014.09.001

Graham, K. A., Mulhall, H. J., Labeed, F. H., Lewis, M. P., Hoettges, K. F., Kalavrezos, N., Porter S R, Hughes, M. P. (2015).A dielectrophoretic method of discrimination between normal oral epithelium, and oral and oropharyngeal cancer in a clinical setting. The Analyst, 140 (15), 5198-5204. doi:10.1039/c5an00796h

James, K., Al-Ali, S., Tarn, J., Cockell, S. J., Gillespie, C. S., Hindmarsh, V., Porter S R, Tomlinson, P. (2015).A transcriptional signature of fatigue derived from patients with primary Sjögren's syndrome. PLoS ONE, 10 (12). doi:10.1371/journal.pone.0143970

Needleman, I., Ashley, P., Fine, P., Haddad, F., Loosemore, M., de Medici, A., Porter, S. (2015).Oral health and elite sport performance. Br J Sports Med, 49 (1), 3-6. doi:10.1136/bjsports-2014-093804Ni

Riordain, R., Hodgson, T., Porter, S., & Fedele, S. (2016).Validity and reliability of the Chronic Oral Mucosal Diseases Questionnaire in a UK population. J Oral Pathol Med. 2016 Sep;45(8):613-6. doi: 10.1111/jop.12425.

Marshall A, Celentano A, Cirillo N, Mignogna MD, McCullough M, Porter S (2016) Antimicrobial activity and regulation of CXCL9 and CXCL10 in oral keratinocytes.Eur J Oral Sci. Oct;124(5):433-439. doi: 10.1111/eos.12293.

Wiriyakijja P, Fedele S, Porter S, Ni Riordain R.J (2016) Web-based information on the treatment of oral leukoplakia - quality and readability. J Oral Pathol Med. Sep;45(8):617-20. doi: 10.1111/jop.12459.